Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.
about
Review of Systemic Immunosuppression for Autoimmune UveitisUstekinumab: differential use in psoriasisHow to translate basic knowledge into clinical application of biologic therapy in spondyloarthritis.Efficacy and cost-efficacy of biologic therapies for moderate to severe psoriasis: a meta-analysis and cost-efficacy analysis using the intention-to-treat principle.
P2860
Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Formulary review of 2 new biol ...... ekinumab for plaque psoriasis.
@ast
Formulary review of 2 new biol ...... ekinumab for plaque psoriasis.
@en
type
label
Formulary review of 2 new biol ...... ekinumab for plaque psoriasis.
@ast
Formulary review of 2 new biol ...... ekinumab for plaque psoriasis.
@en
prefLabel
Formulary review of 2 new biol ...... ekinumab for plaque psoriasis.
@ast
Formulary review of 2 new biol ...... ekinumab for plaque psoriasis.
@en
P2093
P1476
Formulary review of 2 new biol ...... ekinumab for plaque psoriasis.
@en
P2093
Jeremy A Schafer
Nicole K Kjesbo
Patrick P Gleason
P304
P356
10.18553/JMCP.2010.16.6.402
P577
2010-07-01T00:00:00Z